Description
Tirzepatide is a 39-amino acid synthetic twincretin peptide co-activating GLP-1 and GIP receptors. Preclinical research has investigated its effects on beta-cell preservation, adipogenesis, body weight regulation, and insulin sensitivity — areas of significant interest in metabolic disease research.
This 5mg vial is HPLC verified and MS/MS validated to 99%+ purity. COA provided with every order.
For research use only. Not for human or veterinary consumption.




